Eisai to Present Full Findings from Lecanemab Confirmatory Phase 3 Clinical Trial (Clarity AD) and Other Alzheimer’s Disease Research at The 15th Clinical Trials on Alzheimer’s Disease (CTAD) Conference พฤศจิกายน 21, 2022 jcn TOKYO, Nov 21, 2022 – (JCN Newswire via SEAPRWire […]
